Cosmetic composition containing acetylated oligoglucuronans
The present invention relates to the field of cosmetic and dermopharmaceutical compositions. It concerns oligomer compounds of D-glucuronic acid or D-glucuronate with a β (1-4) sequence (or oligoglucuronans) containing a degree of acetylation specifically between 8.7±0.5 and 9.2±0.5% by weight of O—CO—CH 3 group compared to the weight of glucuronic acid and with a degree of polymerisation (DP) of 18-19±2. The oligomer compounds according to the present invention are intended to stimulate the elasticity of the dermis and epidermis although they also act to increase dermo-epidermal cohesion in order to combat skin ageing, lines, wrinkles, visible and/or tactile skin discontinuities, loss of firmness, elasticity and tone and to combat skin tissue deformability. The invention also concerns a cosmetic composition containing at least one compound as recited according to the present invention.
1. A method of improving dermis and epidermis elasticity of skin, comprising:
treating skin, having a dermis and an epidermis, by administering a cosmetic composition comprising an amount of between 0.0001 wt. % and 30 wt. %, relative to the total weight of the cosmetic composition, of a mixture of oligomer compounds of D-glucuronic acid or D-glucuronate having a β (1-4) sequence, wherein the oligomer compounds of D-glucuronic acid or D-glucuronate present in the cosmetic composition consist of oligomer compounds of D-glucuronic acid or D-glucuronate with a degree of acetylation of between 8.7±0.5 and 9.2±0.5 wt. % of O—CO—CH3 groups, relative to the weight of glucuronic acid, a degree of polymerization of 18-19±2, and a weight average molecular weight (Mw) in the range of between 3,600 Da and 3,800 Da; and wherein the mixture of oligomer compounds is represented by formula (I):
wherein:
i) R individually represents a hydrogen atom or an acetyl group;
ii) n represents 15-16; and
iii) the mixture of oligomer compounds is prepared by fermentation with a bacterium comprising a Rhizobium meliloti strain; and
wherein the elasticity of the dermis and epidermis is improved.
2. The method of claim 1 , wherein the administered cosmetic composition increases the elastic properties of the dermis and epidermis.
3. The method of claim 1 , wherein the administered cosmetic composition promotes stimulation of hyaluronic acid synthesis.
4. The method of claim 1 , wherein the administered cosmetic composition promotes expression of CD44 receptors by keratinocytes.
5. The method of claim 1 , wherein the administered cosmetic composition promotes elastin synthesis.
6. The method of claim 1 , wherein the administered cosmetic composition preserves long lasting dermal proteins from glycation.
7. The method of claim 1 , wherein the administered cosmetic composition stimulates the elasticity of the dermis and epidermis.
8. The method of claim 1 , wherein the administered cosmetic composition:
i) strengthens the dermo-epidermal cohesion;
ii) stabilises and strengthens the dermo-epidermal junction; and/or
ii) promotes stimulation of laminin 5 synthesis.
9. The method of claim 1 , wherein the administered cosmetic composition reduces or minimizesskin ageing, lines, wrinkles, visible and/or tactile discontinuities of the skin, loss of firmness, elasticity or tone, and/or deformability of the skintissue.
10. The method of claim 1 , wherein the administered cosmetic composition:
i) moisturizes the skin;
ii) reduces or minimizes skin waterloss; and/or
iii) decontracts, relaxes and/or smoothes the skin.
11. The method of claim 1 , wherein the administered cosmetic composition is applied topically.
12. The method of claim 1 , wherein the administered cosmetic composition treats wrinkles, treats lines, increases skin elasticity, and/or increases dermo-epidermal properties.
13. The method of claim 1 , wherein the administered cosmetic composition further comprises at least one additional active component, comprising:
i) a moisturising agent;
ii) an anti-wrinkle agent;
iii) an anti-inflammatory agent;
iv) an anti-oxidising agent;
v) a sunscreen and/or filter-active substance; or
vi) a lightening agent.
14. The method of claim 1 , wherein the administered cosmetic composition comprises the mixture of oligomer compounds in the form of: a solution; dispersion; emulsion; paste; or powder; wherein the mixture of oligomer compounds is optionally carried individually or pre-mixed with carriers comprising: macrocapsules; microcapsules; nanocapsules; macrospheres; microspheres; nanospheres; liposomes; oleosomes; chylomicrons; macroparticles; microparticles; nanoparticles; macrosponges; microsponges; nanosponges; microemulsions; nanoemulsions; or adsorbed onto powderous organic polymers, talcs, bentonites, or other mineral or organic supports.
15. The method of claim 1 , wherein the administered cosmetic composition comprises a galenic form, comprising: creams; lotions; unguents; milks; creams; gels; emulsions: dispersions; solutions; suspensions; cleansing agents; foundations; anhydrous preparations comprising sticks, lip balm, body oils, and bath oils: shower gels; bath gels; shampoos; hair-care products; make-up removing lotions or milks; lotions; sun-creams or milks; artificial tanning lotions, creams, or milks; shaving creams or foams; aftershave lotions; lipsticks; mascaras or nail varnish; skin essences; serum; adhesive or absorbent material; and/or transdermal patches or powders.
16. The method of claim 1 , wherein the administered cosmetic composition further comprises a physiologically acceptable medium.
17. The method of claim 1 , wherein the administered cosmetic composition comprises the mixture of oligomer compounds of formula (I) in an amount between 1 wt. % and 5 wt. %, compared to the total weight of the composition.